Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes

Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort

(2017) Damon E. Houghton et al.   LEUKEMIA & LYMPHOMA

Guidance for the prevention and treatment of cancer-associated venous thromboembolism

(2016) Alok A. Khorana et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Variability in management of hematologic malignancy patients with venous thromboembolism and chemotherapy-induced thrombocytopenia

(2016) Bethany T. Samuelson et al.   THROMBOSIS RESEARCH

Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer

(2015) Agnes Y. Y. Lee et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients

(2013) Agnes YY Lee et al.   BMC CANCER

Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH

(2013) M. Carrier et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Dose of Prophylactic Platelet Transfusions and Prevention of Hemorrhage

(2010) Sherrill J. Slichter et al.   NEW ENGLAND JOURNAL OF MEDICINE

The National Comprehensive Cancer Center Network (NCCN) guidelines on the management of venous thromboembolism in cancer patients

(2010) Michael B. Streiff   THROMBOSIS RESEARCH

The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention

(2008) D. E. Gerber et al.   BLOOD